Literature DB >> 7900503

Morphology of in vitro sperm phagocytosis by rat peritoneal macrophages under influence of oily contrast medium (Lipiodol).

D Mikulska1, R Kurzawa, L Ròzewicka.   

Abstract

Morphology of sperm phagocytosing rat peritoneal macrophages (PM) in control and Lipiodol added cultures was evaluated under light as well as scanning electron and transmission electron microscopes. The spermiophagic index (SPI) was assessed to estimate an inhibitory effect of Lipiodol on sperm phagocytosis to be compared with the outcome of morphological studies. Lipiodol inhibits in vitro sperm phagocytosis as indicated by SPI and evaluation under light, scanning electron and transmission electron microscopes. The highest SPI was seen in control cultures (14.44), declined in cultures with 0.25% and 0.5% Lipiodol (3.3 and 3.02 respectively) to reach the lowest value with 1% Lipiodol (1.60). The macrophages in cultures with Lipiodol were covered by a thin layer of oily contrast medium. The layer produced changes in the macrophages' shape and the cytoplasmic surface configuration. Lipiodol hinders both sperm phagocytosis and movement of PM by altering their shape and impairing pseudopodia and protrusions formation. Morphological studies of sperm phagocytosis by PM can help explain therapeutic effects of oily contrast media used in hysterosalpingography. Number of studies have suggested therapeutic effects of hysterosalpingography (HSG). These studies have demonstrated an increase in pregnancy rates after HSG in previously infertile women (Fullenlove, 1969; Palmer, 1960). Pregnancies were even more numerous after applying oil, than water based contrast media (DeCharney et al., 1980; Schwabe, 1983). Sawatari et al., 1993 have lately shown, that Lipiodol significantly increases pregnancy rates in animals. Hypothesis has been put forward as to the possibility of modulating activity of these agents exerted upon the peritoneal and oviductal macrophages (Boyer et al., 1986; Schwabe et al., 1983).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7900503

Source DB:  PubMed          Journal:  Acta Eur Fertil        ISSN: 0587-2421


  5 in total

Review 1.  Tubal flushing for subfertility.

Authors:  Lamiya Mohiyiddeen; Anne Hardiman; Cheryl Fitzgerald; Edward Hughes; Ben Willem J Mol; Neil Johnson; Andrew Watson
Journal:  Cochrane Database Syst Rev       Date:  2015-05-01

2.  Tubal flushing with oil- or water-based contrast medium: can we identify markers that indicate treatment benefit?

Authors:  Joukje van Rijswijk; Nienke van Welie; Kim Dreyer; Parvin Tajik; Cornelis B Lambalk; Peter Hompes; Velja Mijatovic; Ben W J Mol; Mohammad H Zafarmand
Journal:  Hum Reprod Open       Date:  2019-07-18

3.  Oil-based versus water-based contrast media for hysterosalpingography in infertile women of advanced age, with ovulation disorders or a high risk for tubal pathology: study protocol of a randomized controlled trial (H2Oil2 study).

Authors:  K Rosielle; D Kamphuis; N van Welie; I Roest; A Mozes; E J P van Santbrink; T van de Laar; A B Hooker; A G Huppelschoten; W Li; M Y Bongers; J Stoker; M van Wely; C Koks; C B Lambalk; A Hemingway; B W J Mol; K Dreyer; V Mijatovic
Journal:  BMC Womens Health       Date:  2022-04-18       Impact factor: 2.742

4.  Preovulatory uterine flushing with saline as a treatment for unexplained infertility: a randomised controlled trial protocol.

Authors:  Sarah Maheux-Lacroix; Sylvie Dodin; Lynne Moore; Emmanuel Bujold; Jessica Lefebvre; Marie-Ève Bergeron
Journal:  BMJ Open       Date:  2016-01-06       Impact factor: 2.692

5.  Treatment effect of oil-based contrast is related to experienced pain at HSG: a post-hoc analysis of the randomised H2Oil study.

Authors:  N van Welie; K Dreyer; J van Rijswijk; H R Verhoeve; M Goddijn; A W Nap; J M J Smeenk; M A F Traas; H G M Rijnsaardt-Lukassen; A J C M van Dongen; P Bourdrez; J P de Bruin; A V Sluijmer; A P Gijsen; P M van de Ven; C B Lambalk; V Mijatovic; B W J Mol
Journal:  Hum Reprod       Date:  2019-12-01       Impact factor: 6.918

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.